Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kai Keen Shiu
Inhibition of EGFR, HER2, and HER3 Signalling in Patients With Colorectal Cancer Wild-Type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): A Phase 2–3 Randomised Trial
Lancet Gastroenterology and Hepatology, The
Hepatology
Gastroenterology
Related publications
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- And PIK3CA- Wild-Type Metastatic Colorectal Cancer: The AGITG Randomised Phase II ICECREAM Study
Clinical Colorectal Cancer
Oncology
Gastroenterology
Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer
Cancer Letters
Cancer Research
Oncology
FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer
Oncology Letters
Cancer Research
Oncology
Evaluation of KRAS, NRAS and BRAF Mutations Detection in Plasma Using an Automated System for Patients With Metastatic Colorectal Cancer
PLoS ONE
Multidisciplinary
Vitamin D Receptor Expression Is Associated With PIK3CA and KRAS Mutations in Colorectal Cancer
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
BRAF, KRAS and PIK3CA Mutations in Colorectal Serrated Polyps and Cancer: Primary or Secondary Genetic Events in Colorectal Carcinogenesis?
BMC Cancer
Cancer Research
Oncology
Genetics
Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients
Neoplasma
Cancer Research
